Purchase Order 75F40123P00255
Award Date 9/15/23
Potential Completion Date 12/28/24
Potential Value $247K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Time and Materials
Place of Performance
College Station, TX 77843, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $247,718 purchase order to Texas A&M Agrilife Research on September 22, 2023, to establish a team of scientific experts specializing in systematic review methodology with expertise in nutrition, toxicology, and evidence integration and synthesis. The contract, which operates on a labor-hours pricing model with an ultimate completion date of December 28, 2024, will be performed in Calverton, Maryland, and involves consultation with FDA personnel...
- The Food and Drug Administration (FDA) awarded a $297,071.74 definitive contract with a firm fixed price to Texas A&M University System Health Science Center to conduct research on in-vitro quality metrics approaches for bioequivalence demonstration between intramammary infusion products for animals. The award was issued on September 27, 2022, with an ultimate completion date of September 29, 2024, and work is being performed in College Station, Texas. This contract emerged from an FDA Broad...
- The Food and Drug Administration (FDA) awarded a $25,000 cost-no-fee purchase order to the National Academy of Sciences (NAS) on November 25, 2019, with an ultimate completion date of November 24, 2020. The contract calls for NAS to convene an ad hoc committee for scanning new evidence on the nutrient content of human milk. This engagement reflects the FDA's reliance on NAS's established expertise in convening expert panels and conducting consensus studies to inform federal policy and regulatory...
- The Food and Drug Administration issued a delivery order to the National Academy of Sciences on May 2, 2023, for a consensus study on challenges in supply, market competition, and regulation of infant formula in the United States, with a ceiling value of $1,045,634.50. Place of performance is Silver Spring, MD. The order was structured as a labor-hours contract with an ultimate completion date of September 29, 2025. Service Contract Inventory reporting shows government-invoiced activity of $62...
- The Food and Drug Administration (FDA) has awarded a $1,728,816.56 delivery order contract to Texas State University for the Texas Tobacco Retailer Inspections Program Task Order. This contract is part of a larger $16,728,277.18 Indefinite Delivery Contract between the FDA and Texas State University focused on providing technical services related to tobacco retail inspections. The contract has a period of performance through July 31, 2025 and does not include a set-aside designation. As a public...
- This is a $400,756 firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to Texas Tech University System. The contract is for research and development to improve detection of plant contaminants in mixed samples through targeted sequencing of 353 nuclear protein coding genes. The contract supports the FDA's regulatory science and innovation objectives under a Broad Agency Announcement, with no set-aside designation. Texas Tech University System has extensive experience...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order valued at $86,043 to Kauffman Michael D (UEI: KCCDQW8C7727) for research on the distribution, prevalence, and movement of foodborne pathogens in small specialty farms producing fresh produce for human consumption. The work will be performed in Wooster, Ohio, with an ultimate completion date of September 29, 2028. This award was modified to advance the start date from October 1, 2025, to September 30, 2025, to...
- The Food and Drug Administration awarded a definitive contract to the Mississippi State Department of Health for the Mississippi MQSA (Milk Quality System Accreditation) program with a ceiling value of $1,255,593.47 on July 29, 2022, with an ultimate completion date of January 28, 2028, under a firm fixed-price, no-set-aside structure. Place of performance is Jackson, MS. The contract supports the FDA's milk quality and safety accreditation mission through the state health department's Finance...
- The Food and Drug Administration (FDA) awarded a definitive cost-no-fee contract valued at $1.09 million to the University of Texas at Austin on September 29, 2020, to investigate the effect of repeat unit ordering on the properties of melt-extruded poly(lactide-coglycolide)-based long-acting implants. The research, to be conducted at UT Austin's Austin, Texas facility, focuses on understanding how the molecular structure and sequencing of polymer repeat units influences the performance...
- This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Connecticut Department of Agriculture (CT DoAg) on September 8, 2021. The $57,223.37 firm-fixed-price contract is for CT DoAg to conduct regulatory inspections of animal food manufacturing facilities in Connecticut. This includes inspections for compliance with regulations related to medicated feeds, the Food Safety Modernization Act Produce Safety Rule, and bovine spongiform...